nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabazitaxel—SLCO1B1—Sulfasalazine—Crohn's disease	0.231	0.385	CbGbCtD
Cabazitaxel—ABCG2—Sulfasalazine—Crohn's disease	0.184	0.305	CbGbCtD
Cabazitaxel—CYP3A5—Sulfasalazine—Crohn's disease	0.102	0.169	CbGbCtD
Cabazitaxel—ABCB1—Prednisone—Crohn's disease	0.0529	0.0881	CbGbCtD
Cabazitaxel—CYP3A4—Prednisone—Crohn's disease	0.0317	0.0528	CbGbCtD
Cabazitaxel—TUBB3—lymphoid tissue—Crohn's disease	0.00508	0.0398	CbGeAlD
Cabazitaxel—TUBB3—digestive system—Crohn's disease	0.00501	0.0393	CbGeAlD
Cabazitaxel—TUBA4A—epithelium—Crohn's disease	0.005	0.0392	CbGeAlD
Cabazitaxel—TUBA4A—smooth muscle tissue—Crohn's disease	0.00482	0.0378	CbGeAlD
Cabazitaxel—TUBA4A—skin of body—Crohn's disease	0.00476	0.0373	CbGeAlD
Cabazitaxel—TUBA4A—mammalian vulva—Crohn's disease	0.00434	0.034	CbGeAlD
Cabazitaxel—Candida infection—Mercaptopurine—Crohn's disease	0.00432	0.0183	CcSEcCtD
Cabazitaxel—Haemorrhoids—Mesalazine—Crohn's disease	0.00418	0.0177	CcSEcCtD
Cabazitaxel—Transaminases increased—Mesalazine—Crohn's disease	0.00404	0.0171	CcSEcCtD
Cabazitaxel—Sepsis—Mercaptopurine—Crohn's disease	0.00393	0.0167	CcSEcCtD
Cabazitaxel—TUBA4A—lymphoid tissue—Crohn's disease	0.00385	0.0302	CbGeAlD
Cabazitaxel—TUBB4A—skin of body—Crohn's disease	0.00381	0.0299	CbGeAlD
Cabazitaxel—TUBA4A—digestive system—Crohn's disease	0.00381	0.0298	CbGeAlD
Cabazitaxel—Intestinal obstruction—Mesalazine—Crohn's disease	0.0036	0.0153	CcSEcCtD
Cabazitaxel—TUBB6—epithelium—Crohn's disease	0.0036	0.0282	CbGeAlD
Cabazitaxel—Herpes zoster—Azathioprine—Crohn's disease	0.00358	0.0152	CcSEcCtD
Cabazitaxel—TUBB—smooth muscle tissue—Crohn's disease	0.00353	0.0277	CbGeAlD
Cabazitaxel—TUBB2A—smooth muscle tissue—Crohn's disease	0.00352	0.0275	CbGeAlD
Cabazitaxel—TUBB2A—skin of body—Crohn's disease	0.00347	0.0272	CbGeAlD
Cabazitaxel—TUBB6—smooth muscle tissue—Crohn's disease	0.00347	0.0272	CbGeAlD
Cabazitaxel—TUBB6—skin of body—Crohn's disease	0.00342	0.0268	CbGeAlD
Cabazitaxel—TUBB2B—mammalian vulva—Crohn's disease	0.00336	0.0263	CbGeAlD
Cabazitaxel—TUBB—mammalian vulva—Crohn's disease	0.00318	0.0249	CbGeAlD
Cabazitaxel—TUBB2A—mammalian vulva—Crohn's disease	0.00316	0.0248	CbGeAlD
Cabazitaxel—TUBB6—mammalian vulva—Crohn's disease	0.00312	0.0245	CbGeAlD
Cabazitaxel—TUBB4A—lymphoid tissue—Crohn's disease	0.00309	0.0242	CbGeAlD
Cabazitaxel—TUBB4A—digestive system—Crohn's disease	0.00305	0.0239	CbGeAlD
Cabazitaxel—TUBB4B—smooth muscle tissue—Crohn's disease	0.00301	0.0236	CbGeAlD
Cabazitaxel—TUBB4B—skin of body—Crohn's disease	0.00298	0.0233	CbGeAlD
Cabazitaxel—Breast disorder—Mercaptopurine—Crohn's disease	0.00297	0.0126	CcSEcCtD
Cabazitaxel—TUBB2B—digestive system—Crohn's disease	0.00295	0.0231	CbGeAlD
Cabazitaxel—TUBB2A—digestive system—Crohn's disease	0.00278	0.0218	CbGeAlD
Cabazitaxel—TUBB6—lymphoid tissue—Crohn's disease	0.00277	0.0217	CbGeAlD
Cabazitaxel—TUBB6—digestive system—Crohn's disease	0.00274	0.0215	CbGeAlD
Cabazitaxel—Rectal haemorrhage—Mesalazine—Crohn's disease	0.00272	0.0115	CcSEcCtD
Cabazitaxel—TUBB4B—mammalian vulva—Crohn's disease	0.00271	0.0213	CbGeAlD
Cabazitaxel—Oropharyngeal pain—Mesalazine—Crohn's disease	0.0027	0.0115	CcSEcCtD
Cabazitaxel—Blood bilirubin increased—Mesalazine—Crohn's disease	0.0026	0.011	CcSEcCtD
Cabazitaxel—Colitis—Azathioprine—Crohn's disease	0.00259	0.011	CcSEcCtD
Cabazitaxel—SLCO1B1—digestive system—Crohn's disease	0.00254	0.0199	CbGeAlD
Cabazitaxel—TUBB4B—lymphoid tissue—Crohn's disease	0.00241	0.0189	CbGeAlD
Cabazitaxel—Cystitis noninfective—Mesalazine—Crohn's disease	0.0024	0.0102	CcSEcCtD
Cabazitaxel—TUBB4B—digestive system—Crohn's disease	0.00238	0.0186	CbGeAlD
Cabazitaxel—Cystitis—Mesalazine—Crohn's disease	0.00237	0.0101	CcSEcCtD
Cabazitaxel—Colitis—Mesalazine—Crohn's disease	0.00236	0.01	CcSEcCtD
Cabazitaxel—Candida infection—Mesalazine—Crohn's disease	0.00234	0.00994	CcSEcCtD
Cabazitaxel—Bladder pain—Mesalazine—Crohn's disease	0.00222	0.00942	CcSEcCtD
Cabazitaxel—TUBA4A—lymph node—Crohn's disease	0.00217	0.017	CbGeAlD
Cabazitaxel—Febrile neutropenia—Prednisone—Crohn's disease	0.00216	0.00916	CcSEcCtD
Cabazitaxel—Immune system disorder—Mercaptopurine—Crohn's disease	0.00205	0.00871	CcSEcCtD
Cabazitaxel—Alopecia—Mercaptopurine—Crohn's disease	0.00201	0.00852	CcSEcCtD
Cabazitaxel—Malnutrition—Mercaptopurine—Crohn's disease	0.00198	0.00839	CcSEcCtD
Cabazitaxel—Renal failure acute—Mesalazine—Crohn's disease	0.00193	0.00819	CcSEcCtD
Cabazitaxel—Atrial fibrillation—Mesalazine—Crohn's disease	0.00188	0.00798	CcSEcCtD
Cabazitaxel—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CPEB4—Crohn's disease	0.00186	0.0525	CbGpPWpGaD
Cabazitaxel—Anaemia—Mercaptopurine—Crohn's disease	0.00183	0.00775	CcSEcCtD
Cabazitaxel—Lethargy—Mesalazine—Crohn's disease	0.00182	0.00772	CcSEcCtD
Cabazitaxel—Gastrointestinal haemorrhage—Mesalazine—Crohn's disease	0.00178	0.00756	CcSEcCtD
Cabazitaxel—Leukopenia—Mercaptopurine—Crohn's disease	0.00177	0.00751	CcSEcCtD
Cabazitaxel—TUBB4A—lymph node—Crohn's disease	0.00174	0.0137	CbGeAlD
Cabazitaxel—TUBB2B—lymph node—Crohn's disease	0.00168	0.0132	CbGeAlD
Cabazitaxel—Arthralgia—Mercaptopurine—Crohn's disease	0.00168	0.00714	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00167	0.00709	CcSEcCtD
Cabazitaxel—Dry skin—Mesalazine—Crohn's disease	0.00163	0.00693	CcSEcCtD
Cabazitaxel—Abdominal pain upper—Mesalazine—Crohn's disease	0.00163	0.00691	CcSEcCtD
Cabazitaxel—Orthostatic hypotension—Mesalazine—Crohn's disease	0.00163	0.00691	CcSEcCtD
Cabazitaxel—Oedema—Mercaptopurine—Crohn's disease	0.00161	0.00685	CcSEcCtD
Cabazitaxel—Breast disorder—Mesalazine—Crohn's disease	0.00161	0.00683	CcSEcCtD
Cabazitaxel—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.0016	0.00681	CcSEcCtD
Cabazitaxel—ABCG2—mammalian vulva—Crohn's disease	0.0016	0.0125	CbGeAlD
Cabazitaxel—TUBB—lymph node—Crohn's disease	0.00159	0.0125	CbGeAlD
Cabazitaxel—TUBB2A—lymph node—Crohn's disease	0.00159	0.0124	CbGeAlD
Cabazitaxel—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00158	0.0067	CcSEcCtD
Cabazitaxel—Gastritis—Mesalazine—Crohn's disease	0.00158	0.00669	CcSEcCtD
Cabazitaxel—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.00157	0.00667	CcSEcCtD
Cabazitaxel—Skin disorder—Mercaptopurine—Crohn's disease	0.00157	0.00665	CcSEcCtD
Cabazitaxel—TUBB6—lymph node—Crohn's disease	0.00156	0.0123	CbGeAlD
Cabazitaxel—Abdominal distension—Mesalazine—Crohn's disease	0.00155	0.00658	CcSEcCtD
Cabazitaxel—Influenza—Mesalazine—Crohn's disease	0.00154	0.00654	CcSEcCtD
Cabazitaxel—Anorexia—Mercaptopurine—Crohn's disease	0.00154	0.00653	CcSEcCtD
Cabazitaxel—Pneumonia—Azathioprine—Crohn's disease	0.00152	0.00643	CcSEcCtD
Cabazitaxel—Infestation NOS—Azathioprine—Crohn's disease	0.00151	0.0064	CcSEcCtD
Cabazitaxel—Infestation—Azathioprine—Crohn's disease	0.00151	0.0064	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00147	0.00624	CcSEcCtD
Cabazitaxel—Dysuria—Mesalazine—Crohn's disease	0.00144	0.00611	CcSEcCtD
Cabazitaxel—Neutropenia—Mesalazine—Crohn's disease	0.00144	0.00611	CcSEcCtD
Cabazitaxel—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00143	0.00607	CcSEcCtD
Cabazitaxel—Pollakiuria—Mesalazine—Crohn's disease	0.00142	0.00604	CcSEcCtD
Cabazitaxel—Decreased appetite—Mercaptopurine—Crohn's disease	0.0014	0.00595	CcSEcCtD
Cabazitaxel—Weight decreased—Mesalazine—Crohn's disease	0.00139	0.00591	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00139	0.00591	CcSEcCtD
Cabazitaxel—Pneumonia—Mesalazine—Crohn's disease	0.00138	0.00586	CcSEcCtD
Cabazitaxel—Infestation—Mesalazine—Crohn's disease	0.00137	0.00583	CcSEcCtD
Cabazitaxel—Infestation NOS—Mesalazine—Crohn's disease	0.00137	0.00583	CcSEcCtD
Cabazitaxel—TUBB4B—lymph node—Crohn's disease	0.00136	0.0107	CbGeAlD
Cabazitaxel—Renal failure—Mesalazine—Crohn's disease	0.00135	0.00573	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Mesalazine—Crohn's disease	0.00135	0.00571	CcSEcCtD
Cabazitaxel—Conjunctivitis—Mesalazine—Crohn's disease	0.00134	0.00566	CcSEcCtD
Cabazitaxel—Urinary tract infection—Mesalazine—Crohn's disease	0.00134	0.00566	CcSEcCtD
Cabazitaxel—Haematuria—Mesalazine—Crohn's disease	0.00131	0.00556	CcSEcCtD
Cabazitaxel—CYP3A5—digestive system—Crohn's disease	0.0013	0.0102	CbGeAlD
Cabazitaxel—Body temperature increased—Mercaptopurine—Crohn's disease	0.00128	0.00541	CcSEcCtD
Cabazitaxel—Immune system disorder—Azathioprine—Crohn's disease	0.00122	0.00519	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Azathioprine—Crohn's disease	0.00122	0.00518	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Mesalazine—Crohn's disease	0.00122	0.00517	CcSEcCtD
Cabazitaxel—Oedema peripheral—Mesalazine—Crohn's disease	0.00121	0.00515	CcSEcCtD
Cabazitaxel—Chills—Azathioprine—Crohn's disease	0.00121	0.00515	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Mesalazine—Crohn's disease	0.00121	0.00514	CcSEcCtD
Cabazitaxel—Arrhythmia—Azathioprine—Crohn's disease	0.00121	0.00513	CcSEcCtD
Cabazitaxel—Urethral disorder—Mesalazine—Crohn's disease	0.00121	0.00513	CcSEcCtD
Cabazitaxel—Alopecia—Azathioprine—Crohn's disease	0.0012	0.00507	CcSEcCtD
Cabazitaxel—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00119	0.00504	CcSEcCtD
Cabazitaxel—TUBB8—Parkin-Ubiquitin Proteasomal System pathway—HSPA1B—Crohn's disease	0.00118	0.0334	CbGpPWpGaD
Cabazitaxel—Eye disorder—Mesalazine—Crohn's disease	0.00115	0.00489	CcSEcCtD
Cabazitaxel—Tinnitus—Mesalazine—Crohn's disease	0.00115	0.00488	CcSEcCtD
Cabazitaxel—Cardiac disorder—Mesalazine—Crohn's disease	0.00114	0.00485	CcSEcCtD
Cabazitaxel—Sepsis—Prednisone—Crohn's disease	0.00113	0.00478	CcSEcCtD
Cabazitaxel—Angiopathy—Mesalazine—Crohn's disease	0.00112	0.00475	CcSEcCtD
Cabazitaxel—Immune system disorder—Mesalazine—Crohn's disease	0.00111	0.00472	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Mesalazine—Crohn's disease	0.00111	0.00471	CcSEcCtD
Cabazitaxel—Chills—Mesalazine—Crohn's disease	0.00111	0.00469	CcSEcCtD
Cabazitaxel—Diarrhoea—Mercaptopurine—Crohn's disease	0.0011	0.00468	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Azathioprine—Crohn's disease	0.00109	0.00464	CcSEcCtD
Cabazitaxel—Alopecia—Mesalazine—Crohn's disease	0.00109	0.00462	CcSEcCtD
Cabazitaxel—Anaemia—Azathioprine—Crohn's disease	0.00109	0.00462	CcSEcCtD
Cabazitaxel—Mental disorder—Mesalazine—Crohn's disease	0.00108	0.00458	CcSEcCtD
Cabazitaxel—Erythema—Mesalazine—Crohn's disease	0.00107	0.00455	CcSEcCtD
Cabazitaxel—Malaise—Azathioprine—Crohn's disease	0.00106	0.00451	CcSEcCtD
Cabazitaxel—Leukopenia—Azathioprine—Crohn's disease	0.00105	0.00447	CcSEcCtD
Cabazitaxel—Dysgeusia—Mesalazine—Crohn's disease	0.00105	0.00446	CcSEcCtD
Cabazitaxel—Back pain—Mesalazine—Crohn's disease	0.00104	0.0044	CcSEcCtD
Cabazitaxel—Muscle spasms—Mesalazine—Crohn's disease	0.00103	0.00438	CcSEcCtD
Cabazitaxel—Vomiting—Mercaptopurine—Crohn's disease	0.00103	0.00435	CcSEcCtD
Cabazitaxel—Myalgia—Azathioprine—Crohn's disease	0.001	0.00426	CcSEcCtD
Cabazitaxel—Arthralgia—Azathioprine—Crohn's disease	0.001	0.00426	CcSEcCtD
Cabazitaxel—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CPEB4—Crohn's disease	0.001	0.0284	CbGpPWpGaD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000996	0.00423	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Mesalazine—Crohn's disease	0.000996	0.00422	CcSEcCtD
Cabazitaxel—Anaemia—Mesalazine—Crohn's disease	0.000992	0.00421	CcSEcCtD
Cabazitaxel—Discomfort—Azathioprine—Crohn's disease	0.000991	0.0042	CcSEcCtD
Cabazitaxel—CYP3A4—digestive system—Crohn's disease	0.000978	0.00766	CbGeAlD
Cabazitaxel—Malaise—Mesalazine—Crohn's disease	0.000968	0.00411	CcSEcCtD
Cabazitaxel—Cardiac failure—Prednisone—Crohn's disease	0.000966	0.0041	CcSEcCtD
Cabazitaxel—Vertigo—Mesalazine—Crohn's disease	0.000964	0.00409	CcSEcCtD
Cabazitaxel—Lethargy—Prednisone—Crohn's disease	0.000962	0.00408	CcSEcCtD
Cabazitaxel—Leukopenia—Mesalazine—Crohn's disease	0.000961	0.00408	CcSEcCtD
Cabazitaxel—Nausea—Mercaptopurine—Crohn's disease	0.000959	0.00407	CcSEcCtD
Cabazitaxel—Infection—Azathioprine—Crohn's disease	0.000955	0.00405	CcSEcCtD
Cabazitaxel—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.000943	0.004	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Azathioprine—Crohn's disease	0.000942	0.00399	CcSEcCtD
Cabazitaxel—Cough—Mesalazine—Crohn's disease	0.000937	0.00397	CcSEcCtD
Cabazitaxel—Skin disorder—Azathioprine—Crohn's disease	0.000934	0.00396	CcSEcCtD
Cabazitaxel—Hypertension—Mesalazine—Crohn's disease	0.000927	0.00393	CcSEcCtD
Cabazitaxel—Arthralgia—Mesalazine—Crohn's disease	0.000914	0.00388	CcSEcCtD
Cabazitaxel—Chest pain—Mesalazine—Crohn's disease	0.000914	0.00388	CcSEcCtD
Cabazitaxel—Myalgia—Mesalazine—Crohn's disease	0.000914	0.00388	CcSEcCtD
Cabazitaxel—Anxiety—Mesalazine—Crohn's disease	0.000911	0.00386	CcSEcCtD
Cabazitaxel—ABCB1—epithelium—Crohn's disease	0.00091	0.00713	CbGeAlD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000907	0.00385	CcSEcCtD
Cabazitaxel—Discomfort—Mesalazine—Crohn's disease	0.000903	0.00383	CcSEcCtD
Cabazitaxel—Hypotension—Azathioprine—Crohn's disease	0.000899	0.00381	CcSEcCtD
Cabazitaxel—Cardiac arrest—Prednisone—Crohn's disease	0.000897	0.0038	CcSEcCtD
Cabazitaxel—Dry mouth—Mesalazine—Crohn's disease	0.000894	0.00379	CcSEcCtD
Cabazitaxel—Confusional state—Mesalazine—Crohn's disease	0.000883	0.00375	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000876	0.00372	CcSEcCtD
Cabazitaxel—Oedema—Mesalazine—Crohn's disease	0.000876	0.00372	CcSEcCtD
Cabazitaxel—Infection—Mesalazine—Crohn's disease	0.00087	0.00369	CcSEcCtD
Cabazitaxel—TUBA4A—Platelet degranulation—F5—Crohn's disease	0.000865	0.0245	CbGpPWpGaD
Cabazitaxel—Dry skin—Prednisone—Crohn's disease	0.000864	0.00367	CcSEcCtD
Cabazitaxel—Nervous system disorder—Mesalazine—Crohn's disease	0.000859	0.00364	CcSEcCtD
Cabazitaxel—Hypokalaemia—Prednisone—Crohn's disease	0.000858	0.00364	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Mesalazine—Crohn's disease	0.000858	0.00364	CcSEcCtD
Cabazitaxel—Tachycardia—Mesalazine—Crohn's disease	0.000855	0.00363	CcSEcCtD
Cabazitaxel—Skin disorder—Mesalazine—Crohn's disease	0.000851	0.00361	CcSEcCtD
Cabazitaxel—Anorexia—Mesalazine—Crohn's disease	0.000835	0.00354	CcSEcCtD
Cabazitaxel—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.000832	0.00353	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00083	0.00352	CcSEcCtD
Cabazitaxel—TUBA4A—Response to elevated platelet cytosolic Ca2+—F5—Crohn's disease	0.000824	0.0233	CbGpPWpGaD
Cabazitaxel—Abdominal distension—Prednisone—Crohn's disease	0.00082	0.00348	CcSEcCtD
Cabazitaxel—Hypotension—Mesalazine—Crohn's disease	0.000819	0.00347	CcSEcCtD
Cabazitaxel—ABCG2—lymph node—Crohn's disease	0.000802	0.00628	CbGeAlD
Cabazitaxel—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000798	0.00339	CcSEcCtD
Cabazitaxel—Feeling abnormal—Azathioprine—Crohn's disease	0.000792	0.00336	CcSEcCtD
Cabazitaxel—ABCB1—mammalian vulva—Crohn's disease	0.000789	0.00618	CbGeAlD
Cabazitaxel—Paraesthesia—Mesalazine—Crohn's disease	0.000787	0.00334	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000786	0.00334	CcSEcCtD
Cabazitaxel—Dyspnoea—Mesalazine—Crohn's disease	0.000781	0.00331	CcSEcCtD
Cabazitaxel—Dyspepsia—Mesalazine—Crohn's disease	0.000771	0.00327	CcSEcCtD
Cabazitaxel—Neutropenia—Prednisone—Crohn's disease	0.000762	0.00323	CcSEcCtD
Cabazitaxel—Decreased appetite—Mesalazine—Crohn's disease	0.000761	0.00323	CcSEcCtD
Cabazitaxel—Body temperature increased—Azathioprine—Crohn's disease	0.00076	0.00323	CcSEcCtD
Cabazitaxel—Abdominal pain—Azathioprine—Crohn's disease	0.00076	0.00323	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000756	0.00321	CcSEcCtD
Cabazitaxel—Fatigue—Mesalazine—Crohn's disease	0.000755	0.0032	CcSEcCtD
Cabazitaxel—TUBB8—Pathogenic Escherichia coli infection—TLR4—Crohn's disease	0.000752	0.0213	CbGpPWpGaD
Cabazitaxel—Constipation—Mesalazine—Crohn's disease	0.000749	0.00318	CcSEcCtD
Cabazitaxel—Pain—Mesalazine—Crohn's disease	0.000749	0.00318	CcSEcCtD
Cabazitaxel—SLCO1B3—Transport of organic anions—ALB—Crohn's disease	0.000748	0.0212	CbGpPWpGaD
Cabazitaxel—Weight decreased—Prednisone—Crohn's disease	0.000737	0.00313	CcSEcCtD
Cabazitaxel—Hyperglycaemia—Prednisone—Crohn's disease	0.000735	0.00312	CcSEcCtD
Cabazitaxel—Feeling abnormal—Mesalazine—Crohn's disease	0.000722	0.00306	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000716	0.00304	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Prednisone—Crohn's disease	0.000712	0.00302	CcSEcCtD
Cabazitaxel—Hypersensitivity—Azathioprine—Crohn's disease	0.000709	0.00301	CcSEcCtD
Cabazitaxel—ABCB1—lymphoid tissue—Crohn's disease	0.000701	0.00549	CbGeAlD
Cabazitaxel—TUBA4A—Parkin-Ubiquitin Proteasomal System pathway—HSPA1B—Crohn's disease	0.000696	0.0197	CbGpPWpGaD
Cabazitaxel—Abdominal pain—Mesalazine—Crohn's disease	0.000692	0.00294	CcSEcCtD
Cabazitaxel—Body temperature increased—Mesalazine—Crohn's disease	0.000692	0.00294	CcSEcCtD
Cabazitaxel—ABCB1—digestive system—Crohn's disease	0.000692	0.00542	CbGeAlD
Cabazitaxel—Diarrhoea—Azathioprine—Crohn's disease	0.000658	0.00279	CcSEcCtD
Cabazitaxel—Hypersensitivity—Mesalazine—Crohn's disease	0.000645	0.00274	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Prednisone—Crohn's disease	0.000641	0.00272	CcSEcCtD
Cabazitaxel—Dizziness—Azathioprine—Crohn's disease	0.000636	0.0027	CcSEcCtD
Cabazitaxel—Asthenia—Mesalazine—Crohn's disease	0.000628	0.00267	CcSEcCtD
Cabazitaxel—Vomiting—Azathioprine—Crohn's disease	0.000611	0.00259	CcSEcCtD
Cabazitaxel—Eye disorder—Prednisone—Crohn's disease	0.00061	0.00259	CcSEcCtD
Cabazitaxel—Flushing—Prednisone—Crohn's disease	0.000605	0.00257	CcSEcCtD
Cabazitaxel—Headache—Azathioprine—Crohn's disease	0.000602	0.00256	CcSEcCtD
Cabazitaxel—Diarrhoea—Mesalazine—Crohn's disease	0.000599	0.00254	CcSEcCtD
Cabazitaxel—TUBB2B—Parkin-Ubiquitin Proteasomal System pathway—HSPA1B—Crohn's disease	0.000597	0.0169	CbGpPWpGaD
Cabazitaxel—TUBB6—Parkin-Ubiquitin Proteasomal System pathway—HSPA1B—Crohn's disease	0.000597	0.0169	CbGpPWpGaD
Cabazitaxel—Angiopathy—Prednisone—Crohn's disease	0.000592	0.00251	CcSEcCtD
Cabazitaxel—TUBB—Parkin-Ubiquitin Proteasomal System pathway—HSPA1B—Crohn's disease	0.000592	0.0167	CbGpPWpGaD
Cabazitaxel—Immune system disorder—Prednisone—Crohn's disease	0.000589	0.0025	CcSEcCtD
Cabazitaxel—Arrhythmia—Prednisone—Crohn's disease	0.000583	0.00247	CcSEcCtD
Cabazitaxel—Dizziness—Mesalazine—Crohn's disease	0.000579	0.00246	CcSEcCtD
Cabazitaxel—TUBB3—Parkin-Ubiquitin Proteasomal System pathway—HSPA1B—Crohn's disease	0.000577	0.0163	CbGpPWpGaD
Cabazitaxel—Alopecia—Prednisone—Crohn's disease	0.000576	0.00245	CcSEcCtD
Cabazitaxel—Mental disorder—Prednisone—Crohn's disease	0.000572	0.00242	CcSEcCtD
Cabazitaxel—Nausea—Azathioprine—Crohn's disease	0.000571	0.00242	CcSEcCtD
Cabazitaxel—Erythema—Prednisone—Crohn's disease	0.000568	0.00241	CcSEcCtD
Cabazitaxel—Malnutrition—Prednisone—Crohn's disease	0.000568	0.00241	CcSEcCtD
Cabazitaxel—TUBB2A—Parkin-Ubiquitin Proteasomal System pathway—HSPA1B—Crohn's disease	0.000559	0.0158	CbGpPWpGaD
Cabazitaxel—Vomiting—Mesalazine—Crohn's disease	0.000557	0.00236	CcSEcCtD
Cabazitaxel—SLCO1B3—Recycling of bile acids and salts—ALB—Crohn's disease	0.000554	0.0157	CbGpPWpGaD
Cabazitaxel—Headache—Mesalazine—Crohn's disease	0.000549	0.00233	CcSEcCtD
Cabazitaxel—TUBB1—Parkin-Ubiquitin Proteasomal System pathway—HSPA1B—Crohn's disease	0.000546	0.0154	CbGpPWpGaD
Cabazitaxel—Ill-defined disorder—Prednisone—Crohn's disease	0.000527	0.00224	CcSEcCtD
Cabazitaxel—Anaemia—Prednisone—Crohn's disease	0.000525	0.00223	CcSEcCtD
Cabazitaxel—Nausea—Mesalazine—Crohn's disease	0.00052	0.00221	CcSEcCtD
Cabazitaxel—Malaise—Prednisone—Crohn's disease	0.000512	0.00217	CcSEcCtD
Cabazitaxel—Vertigo—Prednisone—Crohn's disease	0.00051	0.00216	CcSEcCtD
Cabazitaxel—SLCO1B1—Transport of organic anions—ALB—Crohn's disease	0.000502	0.0142	CbGpPWpGaD
Cabazitaxel—TUBB4A—Parkin-Ubiquitin Proteasomal System pathway—HSPA1B—Crohn's disease	0.00049	0.0139	CbGpPWpGaD
Cabazitaxel—Hypertension—Prednisone—Crohn's disease	0.00049	0.00208	CcSEcCtD
Cabazitaxel—Myalgia—Prednisone—Crohn's disease	0.000483	0.00205	CcSEcCtD
Cabazitaxel—Arthralgia—Prednisone—Crohn's disease	0.000483	0.00205	CcSEcCtD
Cabazitaxel—Anxiety—Prednisone—Crohn's disease	0.000482	0.00204	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.00048	0.00204	CcSEcCtD
Cabazitaxel—Discomfort—Prednisone—Crohn's disease	0.000478	0.00203	CcSEcCtD
Cabazitaxel—Oedema—Prednisone—Crohn's disease	0.000463	0.00197	CcSEcCtD
Cabazitaxel—Infection—Prednisone—Crohn's disease	0.00046	0.00195	CcSEcCtD
Cabazitaxel—Nervous system disorder—Prednisone—Crohn's disease	0.000455	0.00193	CcSEcCtD
Cabazitaxel—Tachycardia—Prednisone—Crohn's disease	0.000452	0.00192	CcSEcCtD
Cabazitaxel—Skin disorder—Prednisone—Crohn's disease	0.00045	0.00191	CcSEcCtD
Cabazitaxel—TUBB4B—Parkin-Ubiquitin Proteasomal System pathway—HSPA1B—Crohn's disease	0.000448	0.0127	CbGpPWpGaD
Cabazitaxel—TUBA4A—Pathogenic Escherichia coli infection—TLR4—Crohn's disease	0.000443	0.0125	CbGpPWpGaD
Cabazitaxel—Anorexia—Prednisone—Crohn's disease	0.000442	0.00187	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000422	0.00179	CcSEcCtD
Cabazitaxel—Paraesthesia—Prednisone—Crohn's disease	0.000416	0.00177	CcSEcCtD
Cabazitaxel—Dyspepsia—Prednisone—Crohn's disease	0.000408	0.00173	CcSEcCtD
Cabazitaxel—Decreased appetite—Prednisone—Crohn's disease	0.000403	0.00171	CcSEcCtD
Cabazitaxel—Fatigue—Prednisone—Crohn's disease	0.0004	0.0017	CcSEcCtD
Cabazitaxel—Constipation—Prednisone—Crohn's disease	0.000396	0.00168	CcSEcCtD
Cabazitaxel—ABCB1—lymph node—Crohn's disease	0.000395	0.0031	CbGeAlD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—F5—Crohn's disease	0.000384	0.0109	CbGpPWpGaD
Cabazitaxel—Feeling abnormal—Prednisone—Crohn's disease	0.000382	0.00162	CcSEcCtD
Cabazitaxel—TUBB2B—Pathogenic Escherichia coli infection—TLR4—Crohn's disease	0.00038	0.0108	CbGpPWpGaD
Cabazitaxel—TUBB6—Pathogenic Escherichia coli infection—TLR4—Crohn's disease	0.00038	0.0108	CbGpPWpGaD
Cabazitaxel—Gastrointestinal pain—Prednisone—Crohn's disease	0.000379	0.00161	CcSEcCtD
Cabazitaxel—TUBB—Pathogenic Escherichia coli infection—TLR4—Crohn's disease	0.000377	0.0107	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Recycling of bile acids and salts—ALB—Crohn's disease	0.000372	0.0105	CbGpPWpGaD
Cabazitaxel—TUBB3—Pathogenic Escherichia coli infection—TLR4—Crohn's disease	0.000367	0.0104	CbGpPWpGaD
Cabazitaxel—Abdominal pain—Prednisone—Crohn's disease	0.000366	0.00155	CcSEcCtD
Cabazitaxel—Body temperature increased—Prednisone—Crohn's disease	0.000366	0.00155	CcSEcCtD
Cabazitaxel—TUBA4A—Metabolism of proteins—SBSPON—Crohn's disease	0.000357	0.0101	CbGpPWpGaD
Cabazitaxel—TUBB2A—Pathogenic Escherichia coli infection—TLR4—Crohn's disease	0.000356	0.0101	CbGpPWpGaD
Cabazitaxel—TUBB1—Pathogenic Escherichia coli infection—TLR4—Crohn's disease	0.000348	0.00984	CbGpPWpGaD
Cabazitaxel—Hypersensitivity—Prednisone—Crohn's disease	0.000341	0.00145	CcSEcCtD
Cabazitaxel—Asthenia—Prednisone—Crohn's disease	0.000333	0.00141	CcSEcCtD
Cabazitaxel—Diarrhoea—Prednisone—Crohn's disease	0.000317	0.00135	CcSEcCtD
Cabazitaxel—TUBB4A—Pathogenic Escherichia coli infection—TLR4—Crohn's disease	0.000312	0.00883	CbGpPWpGaD
Cabazitaxel—TUBB2B—Metabolism of proteins—SBSPON—Crohn's disease	0.000307	0.00867	CbGpPWpGaD
Cabazitaxel—TUBB6—Metabolism of proteins—SBSPON—Crohn's disease	0.000307	0.00867	CbGpPWpGaD
Cabazitaxel—Dizziness—Prednisone—Crohn's disease	0.000306	0.0013	CcSEcCtD
Cabazitaxel—TUBB3—Metabolism of proteins—SBSPON—Crohn's disease	0.000296	0.00838	CbGpPWpGaD
Cabazitaxel—Vomiting—Prednisone—Crohn's disease	0.000295	0.00125	CcSEcCtD
Cabazitaxel—Headache—Prednisone—Crohn's disease	0.00029	0.00123	CcSEcCtD
Cabazitaxel—SLCO1B3—Bile acid and bile salt metabolism—ALB—Crohn's disease	0.00029	0.00819	CbGpPWpGaD
Cabazitaxel—TUBB2A—Metabolism of proteins—SBSPON—Crohn's disease	0.000287	0.00811	CbGpPWpGaD
Cabazitaxel—TUBB4B—Pathogenic Escherichia coli infection—TLR4—Crohn's disease	0.000286	0.00808	CbGpPWpGaD
Cabazitaxel—TUBB1—Metabolism of proteins—SBSPON—Crohn's disease	0.000281	0.00793	CbGpPWpGaD
Cabazitaxel—CYP2C8—Arachidonic acid metabolism—GPX4—Crohn's disease	0.00028	0.00791	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—ALB—Crohn's disease	0.000277	0.00785	CbGpPWpGaD
Cabazitaxel—Nausea—Prednisone—Crohn's disease	0.000275	0.00117	CcSEcCtD
Cabazitaxel—SLCO1B3—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000266	0.00751	CbGpPWpGaD
Cabazitaxel—SLCO1B3—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000266	0.00751	CbGpPWpGaD
Cabazitaxel—TUBA4A—Platelet degranulation—ALB—Crohn's disease	0.000263	0.00743	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—SBSPON—Crohn's disease	0.000252	0.00712	CbGpPWpGaD
Cabazitaxel—TUBA4A—Response to elevated platelet cytosolic Ca2+—ALB—Crohn's disease	0.00025	0.00708	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—SBSPON—Crohn's disease	0.00023	0.00651	CbGpPWpGaD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—IL3—Crohn's disease	0.00023	0.00651	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—LRRK2—Crohn's disease	0.000226	0.00639	CbGpPWpGaD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—RASGRP1—Crohn's disease	0.000223	0.00629	CbGpPWpGaD
Cabazitaxel—TUBB6—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000199	0.00563	CbGpPWpGaD
Cabazitaxel—TUBB2B—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000199	0.00563	CbGpPWpGaD
Cabazitaxel—TUBB6—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000199	0.00563	CbGpPWpGaD
Cabazitaxel—TUBB2B—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000199	0.00563	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—F5—Crohn's disease	0.000198	0.00559	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Bile acid and bile salt metabolism—ALB—Crohn's disease	0.000195	0.0055	CbGpPWpGaD
Cabazitaxel—TUBB3—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000192	0.00543	CbGpPWpGaD
Cabazitaxel—TUBB3—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000192	0.00543	CbGpPWpGaD
Cabazitaxel—SLCO1B3—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000187	0.00529	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—Crohn's disease	0.000186	0.00527	CbGpPWpGaD
Cabazitaxel—TUBB2A—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000186	0.00526	CbGpPWpGaD
Cabazitaxel—TUBB2A—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000186	0.00526	CbGpPWpGaD
Cabazitaxel—TUBB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000182	0.00515	CbGpPWpGaD
Cabazitaxel—TUBB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000182	0.00515	CbGpPWpGaD
Cabazitaxel—SLCO1B1—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000178	0.00505	CbGpPWpGaD
Cabazitaxel—SLCO1B1—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000178	0.00505	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000167	0.00472	CbGpPWpGaD
Cabazitaxel—ABCG2—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	0.000166	0.00469	CbGpPWpGaD
Cabazitaxel—SLCO1B3—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000165	0.00468	CbGpPWpGaD
Cabazitaxel—TUBB4A—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000163	0.00462	CbGpPWpGaD
Cabazitaxel—TUBB4A—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000163	0.00462	CbGpPWpGaD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	0.000161	0.00456	CbGpPWpGaD
Cabazitaxel—TUBB4B—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000149	0.00423	CbGpPWpGaD
Cabazitaxel—TUBB4B—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000149	0.00423	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000142	0.00401	CbGpPWpGaD
Cabazitaxel—TUBB2B—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.00014	0.00396	CbGpPWpGaD
Cabazitaxel—TUBB6—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.00014	0.00396	CbGpPWpGaD
Cabazitaxel—TUBB3—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000135	0.00383	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000135	0.00382	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000135	0.00382	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—UBE2D1—Crohn's disease	0.000132	0.00374	CbGpPWpGaD
Cabazitaxel—TUBB2A—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000131	0.00371	CbGpPWpGaD
Cabazitaxel—TUBB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000128	0.00362	CbGpPWpGaD
Cabazitaxel—SLCO1B1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000126	0.00356	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.000125	0.00354	CbGpPWpGaD
Cabazitaxel—TUBB6—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000124	0.0035	CbGpPWpGaD
Cabazitaxel—TUBB2B—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000124	0.0035	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—ITGA4—Crohn's disease	0.000122	0.00344	CbGpPWpGaD
Cabazitaxel—TUBB3—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.00012	0.00338	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—IL17A—Crohn's disease	0.000119	0.00335	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—IL3—Crohn's disease	0.000119	0.00335	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metapathway biotransformation—GPX4—Crohn's disease	0.000119	0.00335	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—UBE2D1—Crohn's disease	0.000118	0.00335	CbGpPWpGaD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—ALB—Crohn's disease	0.000117	0.00329	CbGpPWpGaD
Cabazitaxel—TUBB2A—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000116	0.00328	CbGpPWpGaD
Cabazitaxel—TUBB4A—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000115	0.00325	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—RASGRP1—Crohn's disease	0.000115	0.00324	CbGpPWpGaD
Cabazitaxel—TUBB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000113	0.0032	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—UBE2D1—Crohn's disease	0.000113	0.00318	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000112	0.00317	CbGpPWpGaD
Cabazitaxel—SLCO1B1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000111	0.00314	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000111	0.00313	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—IL12B—Crohn's disease	0.00011	0.00312	CbGpPWpGaD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	0.000108	0.00306	CbGpPWpGaD
Cabazitaxel—TUBB4B—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000105	0.00298	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000104	0.00293	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metapathway biotransformation—GPX4—Crohn's disease	0.000103	0.0029	CbGpPWpGaD
Cabazitaxel—TUBB4A—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000102	0.00288	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—UBE2D1—Crohn's disease	0.000101	0.00285	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	9.54e-05	0.0027	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Transmembrane transport of small molecules—GCKR—Crohn's disease	9.51e-05	0.00269	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—UBE2D1—Crohn's disease	9.32e-05	0.00264	CbGpPWpGaD
Cabazitaxel—TUBB4B—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	9.3e-05	0.00263	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	9.07e-05	0.00256	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	9.07e-05	0.00256	CbGpPWpGaD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	8.96e-05	0.00253	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—UBE2D1—Crohn's disease	8.53e-05	0.00241	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	8.41e-05	0.00238	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	8.4e-05	0.00237	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	8.4e-05	0.00237	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—UBE2D1—Crohn's disease	8.34e-05	0.00236	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—IL2RA—Crohn's disease	8.31e-05	0.00235	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—IL10—Crohn's disease	8.06e-05	0.00228	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—UBE2D1—Crohn's disease	7.63e-05	0.00216	CbGpPWpGaD
Cabazitaxel—CYP2C8—Arachidonic acid metabolism—PTGS2—Crohn's disease	7.52e-05	0.00213	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PLA2G4F—Crohn's disease	7.44e-05	0.0021	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	7.43e-05	0.0021	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—IL2RA—Crohn's disease	7.19e-05	0.00203	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	6.96e-05	0.00197	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	6.45e-05	0.00182	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—GCKR—Crohn's disease	6.39e-05	0.00181	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—MTMR3—Crohn's disease	6.32e-05	0.00179	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—ALB—Crohn's disease	6.01e-05	0.0017	CbGpPWpGaD
Cabazitaxel—SLCO1B3—SLC-mediated transmembrane transport—ALB—Crohn's disease	5.96e-05	0.00168	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—GCKR—Crohn's disease	5.92e-05	0.00167	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	5.65e-05	0.0016	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—JAK2—Crohn's disease	5.58e-05	0.00158	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	5.51e-05	0.00156	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	5.48e-05	0.00155	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	5.23e-05	0.00148	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	5.06e-05	0.00143	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PLA2G4F—Crohn's disease	5e-05	0.00141	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—FADS1—Crohn's disease	4.93e-05	0.00139	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—IFNG—Crohn's disease	4.74e-05	0.00134	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PLA2G4F—Crohn's disease	4.63e-05	0.00131	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—GPX4—Crohn's disease	4.61e-05	0.0013	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	4.54e-05	0.00128	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	4.54e-05	0.00128	CbGpPWpGaD
Cabazitaxel—TUBB6—Transmembrane transport of small molecules—ALB—Crohn's disease	4.46e-05	0.00126	CbGpPWpGaD
Cabazitaxel—TUBB2B—Transmembrane transport of small molecules—ALB—Crohn's disease	4.46e-05	0.00126	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—GCKR—Crohn's disease	4.45e-05	0.00126	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	4.41e-05	0.00125	CbGpPWpGaD
Cabazitaxel—TUBB3—Transmembrane transport of small molecules—ALB—Crohn's disease	4.31e-05	0.00122	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	4.27e-05	0.00121	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—MTMR3—Crohn's disease	4.25e-05	0.0012	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—IL1B—Crohn's disease	4.23e-05	0.0012	CbGpPWpGaD
Cabazitaxel—TUBB2A—Transmembrane transport of small molecules—ALB—Crohn's disease	4.17e-05	0.00118	CbGpPWpGaD
Cabazitaxel—TUBB1—Transmembrane transport of small molecules—ALB—Crohn's disease	4.08e-05	0.00115	CbGpPWpGaD
Cabazitaxel—TUBA4A—Metabolism of proteins—CXCL8—Crohn's disease	4.01e-05	0.00113	CbGpPWpGaD
Cabazitaxel—SLCO1B1—SLC-mediated transmembrane transport—ALB—Crohn's disease	4e-05	0.00113	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	4e-05	0.00113	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—MTMR3—Crohn's disease	3.93e-05	0.00111	CbGpPWpGaD
Cabazitaxel—TUBB4A—Transmembrane transport of small molecules—ALB—Crohn's disease	3.66e-05	0.00104	CbGpPWpGaD
Cabazitaxel—TUBB2B—Metabolism of proteins—CXCL8—Crohn's disease	3.44e-05	0.000973	CbGpPWpGaD
Cabazitaxel—TUBB6—Metabolism of proteins—CXCL8—Crohn's disease	3.44e-05	0.000973	CbGpPWpGaD
Cabazitaxel—TUBB4B—Transmembrane transport of small molecules—ALB—Crohn's disease	3.35e-05	0.000947	CbGpPWpGaD
Cabazitaxel—TUBB3—Metabolism of proteins—CXCL8—Crohn's disease	3.32e-05	0.000939	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PLA2G4F—Crohn's disease	3.31e-05	0.000937	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—FADS1—Crohn's disease	3.31e-05	0.000936	CbGpPWpGaD
Cabazitaxel—TUBB2A—Metabolism of proteins—CXCL8—Crohn's disease	3.22e-05	0.00091	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	3.2e-05	0.000905	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.18e-05	0.0009	CbGpPWpGaD
Cabazitaxel—TUBB1—Metabolism of proteins—CXCL8—Crohn's disease	3.15e-05	0.00089	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—GPX4—Crohn's disease	3.1e-05	0.000876	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—TNF—Crohn's disease	3.07e-05	0.000868	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—FADS1—Crohn's disease	3.06e-05	0.000867	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Transmembrane transport of small molecules—ALB—Crohn's disease	3.03e-05	0.000856	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—GCKR—Crohn's disease	2.99e-05	0.000846	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PLA2G4F—Crohn's disease	2.87e-05	0.000812	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GPX4—Crohn's disease	2.87e-05	0.000811	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	2.83e-05	0.0008	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—CXCL8—Crohn's disease	2.82e-05	0.000799	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—MTMR3—Crohn's disease	2.82e-05	0.000797	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.78e-05	0.000788	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GCKR—Crohn's disease	2.77e-05	0.000784	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—CXCL8—Crohn's disease	2.58e-05	0.000731	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PLA2G4F—Crohn's disease	2.5e-05	0.000707	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—MTMR3—Crohn's disease	2.44e-05	0.00069	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	2.24e-05	0.000634	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—FADS1—Crohn's disease	2.2e-05	0.000621	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.14e-05	0.000605	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—MTMR3—Crohn's disease	2.13e-05	0.000601	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GPX4—Crohn's disease	2.06e-05	0.000581	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—ALB—Crohn's disease	2.03e-05	0.000575	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GCKR—Crohn's disease	1.99e-05	0.000561	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—FADS1—Crohn's disease	1.9e-05	0.000538	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—ALB—Crohn's disease	1.88e-05	0.000533	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.87e-05	0.000529	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GPX4—Crohn's disease	1.78e-05	0.000504	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GCKR—Crohn's disease	1.72e-05	0.000486	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—FADS1—Crohn's disease	1.66e-05	0.000468	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GPX4—Crohn's disease	1.55e-05	0.000439	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	1.54e-05	0.000436	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	1.51e-05	0.000428	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GCKR—Crohn's disease	1.5e-05	0.000424	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—ALB—Crohn's disease	1.42e-05	0.000401	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—MTMR3—Crohn's disease	1.31e-05	0.00037	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PTGS2—Crohn's disease	1.24e-05	0.000351	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.23e-05	0.000348	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.08e-05	0.000304	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—FADS1—Crohn's disease	1.02e-05	0.000289	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.02e-05	0.000288	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GPX4—Crohn's disease	9.56e-06	0.00027	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—ALB—Crohn's disease	9.52e-06	0.000269	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GCKR—Crohn's disease	9.23e-06	0.000261	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—ALB—Crohn's disease	8.82e-06	0.000249	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PTGS2—Crohn's disease	8.33e-06	0.000236	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PTGS2—Crohn's disease	7.72e-06	0.000218	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—ALB—Crohn's disease	6.32e-06	0.000179	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PTGS2—Crohn's disease	5.53e-06	0.000156	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ALB—Crohn's disease	5.47e-06	0.000155	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PTGS2—Crohn's disease	4.79e-06	0.000135	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ALB—Crohn's disease	4.77e-06	0.000135	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PTGS2—Crohn's disease	4.17e-06	0.000118	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ALB—Crohn's disease	2.94e-06	8.31e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PTGS2—Crohn's disease	2.57e-06	7.27e-05	CbGpPWpGaD
